The PiZ gene of α1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis
- 1 September 1995
- journal article
- Published by Elsevier in Kidney International
- Vol. 48 (3) , 844-850
- https://doi.org/10.1038/ki.1995.360
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Strong link between the alpha1‐antitrypsin PiZ allele and Wegener's granulomatosisJournal of Internal Medicine, 1994
- Alpha1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitisKidney International, 1993
- IgG subclasses of antineutrophil cytoplasm autoantibodies (ANCA)Nephrology Dialysis Transplantation, 1993
- ANCA and associated diseases: immunodiagnostic and pathogenetic aspectsClinical and Experimental Immunology, 1993
- Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activityClinical and Experimental Immunology, 1992
- How Are Antineutrophil Cytoplasmic Autoantibodies Detected?American Journal of Kidney Diseases, 1991
- Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy.Journal of Clinical Investigation, 1990
- Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme.The Journal of Experimental Medicine, 1990
- AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSISThe Lancet, 1985
- Monoclonal antibody specific for the mutant PiZ alpha 1-antitrypsin and its application in an ELISA procedure for identification of PiZ gene carriers.Proceedings of the National Academy of Sciences, 1984